BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang G, Zhang L, Li R, Wang L. The role of microRNAs in gallbladder cancer. Mol Clin Oncol. 2016;5:7-13. [PMID: 27330755 DOI: 10.3892/mco.2016.905] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Yang G, Lu Z, Meng F, Wan Y, Zhang L, Xu Q, Wang Z. Circulating miR-141 as a potential biomarker for diagnosis, prognosis and therapeutic targets in gallbladder cancer. Sci Rep 2022;12:10072. [PMID: 35710767 DOI: 10.1038/s41598-022-13430-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Ahmad E, Ali A, Nimisha, Kumar Sharma A, Apurva, Kumar A, Mehdi G, Sumayya Abdul Sattar R, Verma R, Mahajan B, Singh Saluja S. Molecular markers in cancer. Clinica Chimica Acta 2022. [DOI: 10.1016/j.cca.2022.05.029] [Reference Citation Analysis]
3 Goyal B, Gupta T, Gupta S, Gupta A. Noncoding ribonucleic acids in gallbladder cancer patients. Clinical Applications of Non-Coding RNAs in Cancer 2022. [DOI: 10.1016/b978-0-12-824550-7.00001-1] [Reference Citation Analysis]
4 Rompianesi G, Di Martino M, Gordon-Weeks A, Montalti R, Troisi R. Liquid biopsy in cholangiocarcinoma: Current status and future perspectives. World J Gastrointest Oncol 2021;13:332-50. [PMID: 34040697 DOI: 10.4251/wjgo.v13.i5.332] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 15] [Article Influence: 15.0] [Reference Citation Analysis]
5 Zhang GF, Wu JC, Wang HY, Jiang WD, Qiu L. Overexpression of microRNA-205-5p exerts suppressive effects on stem cell drug resistance in gallbladder cancer by down-regulating PRKCE. Biosci Rep 2020;40:BSR20194509. [PMID: 32869841 DOI: 10.1042/BSR20194509] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
6 Li K, Zhou Z, Li J, Xiang R. miR-146b Functions as an Oncogene in Oral Squamous Cell Carcinoma by Targeting HBP1. Technol Cancer Res Treat 2020;19:1533033820959404. [PMID: 33327874 DOI: 10.1177/1533033820959404] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Tiwari PK. Epigenetic Biomarkers in Gallbladder Cancer. Trends Cancer 2020;6:540-3. [PMID: 32291238 DOI: 10.1016/j.trecan.2020.03.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
8 Kong J, Wang W. A Systemic Review on the Regulatory Roles of miR-34a in Gastrointestinal Cancer. Onco Targets Ther 2020;13:2855-72. [PMID: 32308419 DOI: 10.2147/OTT.S234549] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
9 Montalvo-Jave EE, Rahnemai-Azar AA, Papaconstantinou D, Deloiza ME, Tsilimigras DI, Moris D, Mendoza-Barrera GE, Weber SM, Pawlik TM. Molecular pathways and potential biomarkers in gallbladder cancer: A comprehensive review. Surg Oncol. 2019;31:83-89. [PMID: 31541911 DOI: 10.1016/j.suronc.2019.09.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
10 D'Almeida O, Mothar O, Bondzie EA, Lieumo Y, Tagne L, Gupta S, Volkert T, Levine S, Tagne JB. Encapsulated miR-200c and Nkx2.1 in a nuclear/mitochondria transcriptional regulatory network of non-metastatic and metastatic lung cancer cells. BMC Cancer 2019;19:136. [PMID: 30744585 DOI: 10.1186/s12885-019-5337-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
11 Diab M, Philip PA. Gallbladder Cancer: Current and Emerging Therapies. Textbook of Gastrointestinal Oncology 2019. [DOI: 10.1007/978-3-030-18890-0_12] [Reference Citation Analysis]
12 Zhang M, Gong W, Zuo B, Chu B, Tang Z, Zhang Y, Yang Y, Zhou D, Weng M, Qin Y, Ma M, Jiang A, Ma F, Quan Z. The microRNA miR-33a suppresses IL-6-induced tumor progression by binding Twist in gallbladder cancer. Oncotarget 2016;7:78640-52. [PMID: 27769047 DOI: 10.18632/oncotarget.12693] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 6.0] [Reference Citation Analysis]
13 Xu S, Zhan M, Wang J. Epithelial-to-mesenchymal transition in gallbladder cancer: from clinical evidence to cellular regulatory networks. Cell Death Discov 2017;3:17069. [PMID: 29188076 DOI: 10.1038/cddiscovery.2017.69] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
14 Paliogiannis P, Latte G, Imam KB. Noncoding RNAs in Gallbladder Cancer. Updates in Gallbladder Diseases 2017. [DOI: 10.5772/67682] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
15 Hu Y, Qin X, Yan D, Cao H, Zhou L, Fan F, Zang J, Ni J, Xu X, Sha H, Liu S, Yu S, Wu J, Ma R, Feng J. Genome-wide profiling of micro-RNA expression in gefitinib-resistant human lung adenocarcinoma using microarray for the identification of miR-149-5p modulation. Tumour Biol 2017;39:1010428317691659. [PMID: 28345454 DOI: 10.1177/1010428317691659] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
16 Ferreira Martins NN, da Silva Oliveira KC, Braga Bona A, de Arruda Cardoso Smith M, Ishak G, Assumpção PP, Burbano RR, Calcagno DQ. The Emerging Role of miRNAs and Their Clinical Implication in Biliary Tract Cancer. Gastroenterol Res Pract 2016;2016:9797410. [PMID: 28115929 DOI: 10.1155/2016/9797410] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]